NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

The trial was first submitted to clinical trials.gov on September 17, 2002.

After several design modifications, the trial ran from August 2007 to November 2015, 331 patients with nGBM were enrolled.

The Company undertook a limited period of enrollment in 2008, and then kept the trial going with the patients already enrolled, but suspended new enrollment due to resource constraints during the worst of the economic downturn, through the end of 2010. The Company began the process of reactivating clinical trial sites for new enrollment in Q1 2011, and resumed screening in Q2 of 2011.

The company reached data lock in October of 2020. The trial was about 13 years old at that point.

The trial is continuing to collect important long term “follow up” survival data. The trial is currently over 16 years old, with patient data spanning over eight to sixteen years.

I have to attend to some other things today, so maybe someone else can help you out with your other questions.